University of the Sciences, Techniques and Technologies of Bamako Report issue

Academic/Hospital Phase 1 Phase 2 Phase 3

Organization Overview

First Clinical Trial
2013
NCT01614964
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2023

Timeline

NOW
  • Now

Alternative names

Malaria Research and Training Center; Faculté de Médecine Pharmacie d'Odontostomatologie; University of Sciences, Techniques, & Technologies of Bamako (USTTB) | MRTC, Univ. of Science, Techniques and Technology, Bamako, Mali | University Clinical Research Center, Mali | University Clinical Research Center - USTTB - Mali | University of Sciences Techniques and Technologies of Bamako-Mali, Africa | University of Sciences, Techniques, & Technologies of Bamako (USTTB) | University of the Sciences, Techniques and Technologies of Bamako

Active Ingredients

Drugs in Phase 3 Trials (2)

artemether (1 trial)

lumefantrine (Coartem) (2 trials)

Drugs in Phase 2 Trials (4)

aq-13 (1 trial)

coartem (1 trial)

l9ls (2 trials)

pfspz (1 trial)

Drugs in Phase 1 Trials (5)

amodiaquine (camoquin) (1 trial)

dihydroartemisinin (1 trial)

piperaquine (1 trial)

pyrimethamine (daraprim) (1 trial)

sulfadoxine (1 trial)

Drugs in Other Trials (2)

oryza sativa (1 trial)

vitamin a (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Body Weight (Phase 3)

Malaria (Phase 3)

Malaria, Falciparum (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 7
  • # of Trial APIs: 13